Payment overview · 2025
General Payments
$39.40
2 reported records · 2 companies
Healthcare provider profile · identity verified
Lynn Collins
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · INDIANAPOLIS, IN · NPI 1659731602
Verified facts
What the public records show
CMS Open Payments records show Lynn Collins received $39.40 in general payments during 2025 across 2 reported records.
Smith+Nephew, Inc. accounted for 64.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $25.53 | 64.8% | 1 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $13.87 | 35.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $39.40 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $25.53 | 1 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $13.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 502 | 84 |
| Sertraline Hcl | Sertraline Hcl | 365 | 42 |
| Gabapentin | Gabapentin | 335 | 53 |
| Trazodone Hcl | Trazodone Hcl | 312 | 47 |
| Levothyroxine Sodium | Levothyroxine Sodium | 309 | 56 |
| Amlodipine Besylate | Amlodipine Besylate | 267 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 240 | 41 |
| Potassium Chloride | Potassium Chloride | 218 | 49 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 205 | 60 |
| Eliquis | Apixaban | 201 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 193 | 28 |
| Losartan Potassium | Losartan Potassium | 181 | 29 |
| Omeprazole | Omeprazole | 181 | 29 |
| Furosemide | Furosemide | 168 | 32 |
| Lisinopril | Lisinopril | 161 | 32 |
| Buspirone Hcl | Buspirone Hcl | 126 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 120 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 118 | 30 |
| Nystatin | Nystatin | 114 | 37 |
| Metformin Hcl | Metformin Hcl | 107 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 103 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 23 |
| Mirtazapine | Mirtazapine | 85 | 17 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 81 | 16 |
| Torsemide | Torsemide | 81 | 19 |
| Carvedilol | Carvedilol | 78 | 15 |
| Jardiance | Empagliflozin | 77 | 14 |
| Gemtesa | Vibegron | 76 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 14 |
| Tramadol Hcl | Tramadol Hcl | 74 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 74 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 72 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 71 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 67 | 36 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 67 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 65 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 64 | suppressed |
| Allopurinol | Allopurinol | 63 | 11 |
| Myrbetriq | Mirabegron | 63 | suppressed |
| Olanzapine | Olanzapine | 61 | suppressed |
| Aripiprazole | Aripiprazole | 60 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | suppressed |
| Ozempic | Semaglutide | 54 | 12 |
| Cephalexin | Cephalexin | 53 | 38 |
| Bupropion Xl | Bupropion Hcl | 52 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 51 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 49 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 48 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 48 | suppressed |
| Famotidine | Famotidine | 47 | 13 |
| Meclizine Hcl | Meclizine Hcl | 46 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 44 | suppressed |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 12 |
| Metformin Hcl Er | Metformin Hcl | 42 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 41 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | suppressed |
| Memantine Hcl | Memantine Hcl | 39 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 37 | 31 |
| Simvastatin | Simvastatin | 37 | suppressed |
| Topiramate | Topiramate | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 30 |
| Spironolactone | Spironolactone | 36 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 35 | suppressed |
| Pregabalin | Pregabalin | 34 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 33 | suppressed |
| Valsartan | Valsartan | 33 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Mounjaro | Tirzepatide | 32 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | suppressed |
| Loperamide | Loperamide Hcl | 30 | 17 |
| Prednisone | Prednisone | 30 | 14 |
| Baclofen | Baclofen | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Alprazolam | Alprazolam | 27 | 12 |
| Ondansetron Odt | Ondansetron | 27 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | 15 |
| Ammonium Lactate | Ammonium Lactate | 26 | suppressed |
| Atenolol | Atenolol | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 21 |
| Clonazepam | Clonazepam | 25 | 12 |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Latanoprost | Latanoprost | 25 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Risperidone | Risperidone | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 22 | suppressed |
| Ubrelvy | Ubrogepant | 22 | suppressed |
| Finasteride | Finasteride | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Cefdinir | Cefdinir | 20 | 16 |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Fluconazole | Fluconazole | 17 | 13 |
| Lidocaine | Lidocaine | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Ezetimibe | Ezetimibe | 15 | suppressed |
| Meloxicam | Meloxicam | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Azithromycin | Azithromycin | 12 | 12 |
| Belsomra | Suvorexant | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Demeclocycline Hcl | Demeclocycline Hcl | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | 11 |
| Lovastatin | Lovastatin | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Pentasa | Mesalamine | 11 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $39.40 · 2 records | Smith+Nephew, Inc. | COLLAGENASE SANTYL, NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error